Beta and Gamma Amino Acid-Substituted Benzenesulfonamides as Inhibitors of Human Carbonic Anhydrases.
Benas BalandisTomas ŠimkūnasVaida Paketurytė-LatvėVilma MichailovienėAurelija MickevičiūtėElena ManakovaSaulius GražulisSergey BelyakovVisvaldas KairysVytautas MickevičiusAsta ZubrienėDaumantas MatulisPublished in: Pharmaceuticals (Basel, Switzerland) (2022)
A series of novel benzenesulfonamide derivatives were synthesized bearing para - N β,γ-amino acid or para - N β-amino acid and thiazole moieties and their binding to the human carbonic anhydrase (CA) isozymes determined. These enzymes are involved in various illnesses, such as glaucoma, altitude sickness, epilepsy, obesity, and even cancer. There are numerous compounds that are inhibitors of CA and used as pharmaceuticals. However, most of them bind to most CA isozymes with little selectivity. The design of high affinity and selectivity towards one CA isozyme remains a significant challenge. The beta and gamma amino acid-substituted compound affinities were determined by the fluorescent thermal shift assay and isothermal titration calorimetry for all 12 catalytically active human carbonic anhydrase isozymes, showing the full affinity and selectivity profile. The structures of several compounds were determined by X-ray crystallography, and the binding mode in the active site of CA enzyme was shown.
Keyphrases
- amino acid
- endothelial cells
- induced pluripotent stem cells
- protein kinase
- high resolution
- metabolic syndrome
- insulin resistance
- molecular docking
- magnetic resonance imaging
- magnetic resonance
- physical activity
- skeletal muscle
- young adults
- computed tomography
- lymph node metastasis
- squamous cell
- molecular dynamics simulations
- oxide nanoparticles